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Abstract
Colonization of the human stomach by Helicobacter pylori is an important risk factor for development of gastric cancer. The
H. pylori cag pathogenicity island (cag PAI) encodes components of a type IV secretion system (T4SS) that translocates the
bacterial oncoprotein CagA into gastric epithelial cells, and CagL is a specialized component of the cag T4SS that binds the
host receptor a5b1 integrin. Here, we utilized a mass spectrometry-based approach to reveal co-purification of CagL, CagI
(another integrin-binding protein), and CagH (a protein with weak sequence similarity to CagL). These three proteins are
encoded by contiguous genes in the cag PAI, and are detectable on the bacterial surface. All three proteins are required for
CagA translocation into host cells and H. pylori-induced IL-8 secretion by gastric epithelial cells; however, these proteins are
not homologous to components of T4SSs in other bacterial species. Scanning electron microscopy analysis reveals that
these proteins are involved in the formation of pili at the interface between H. pylori and gastric epithelial cells. DcagI and
DcagL mutant strains fail to form pili, whereas a DcagH mutant strain exhibits a hyperpiliated phenotype and produces pili
that are elongated and thickened compared to those of the wild-type strain. This suggests that pilus dimensions are
regulated by CagH. A conserved C-terminal hexapeptide motif is present in CagH, CagI, and CagL. Deletion of these motifs
results in abrogation of CagA translocation and IL-8 induction, and the C-terminal motifs of CagI and CagL are required for
formation of pili. In summary, these results indicate that CagH, CagI, and CagL are components of a T4SS subassembly
involved in pilus biogenesis, and highlight the important role played by unique constituents of the H. pylori cag T4SS.
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Introduction
Helicobacter pylori infection is associated with a significantly
increased risk for the development of several gastric diseases,
including peptic ulceration, gastric adenocarcinoma, and gastric
lymphoma [1-4]. H. pylori is a genetically diverse species, and the
risk of developing these diseases is dependent in part on
characteristics of the H. pylori strain with which an individual is
infected. In particular, H. pylori strains harboring the cag
pathogenicity island are associated with a higher rate of disease
than are strains lacking this determinant [5–7].
The cag pathogenicity island is a 40-kilobase chromosomal
region that is predicted to encode 27 proteins [8,9]. One of these
proteins, CagA, is an immunodominant antigen that enters gastric
epithelial cells and causes numerous cellular alterations [10–13].
Additional proteins encoded by the cag PAI comprise a type IV
secretion system (T4SS) that translocates CagA into gastric
epithelial cells [11,12,14–17]. Following translocation, CagA is
phosphorylated by host cell kinases at tyrosine residues contained
within EPIYA motifs in the C-terminal region of the protein
[10,14,18]. CagA, in both phosphorylated and non-phosphorylat-
ed forms, is able to interact with host cell signaling proteins,
resulting in an assortment of consequences, including cytoskeletal
alterations, disruption of cellular junctions, and altered cellular
adhesion and polarity [10–12,19].
When co-cultured with gastric epithelial cells, H. pylori strains
containing the cag PAI stimulate gastric epithelial cells to
synthesize and secrete proinflammatory cytokines, such as
interleukin-8 (IL-8) [20,21]. One mechanism leading to IL-8
induction involves entry of H. pylori peptidoglycan into the
epithelial cell cytoplasm, where it is recognized by the pathogen
recognition molecule NOD1; entry of peptidoglycan into the
cytoplasm occurs through a cag PAI-dependent process [22]. A
second mechanism leading to IL-8 induction involves transloca-
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transcription via activation of the Ras/Raf signaling pathway [23];
upregulation of IL-8 transcription by CagA is detectable in some
CagA-positive strains but not others [23–26].
T4SSs are utilized by a wide variety of bacterial species for
delivery of effector proteins or DNA-protein complexes into an
assortment of recipient cells, including mammalian cells, plant
cells, fungi, or other bacteria [27–31]. Our current under-
standing of bacterial T4SSs is based in large part on elegant
studies of the Agrobacterium tumefaciens T4SS, which translocates
bacterial DNA into plant cells [28,30]. Thus far there has been
relatively little study of the H. pylori cag T4SS. Initial
identification of bacterial genes required for function of the
H. pylori cag T4SS was accomplished by systematic transposon
mutagenesis of genes within the cag PAI [21], or by inserting
antibiotic cassettes into selected genes within the cag PAI
[8,9,32]. One study reported that 17 cag genes are required for
translocation of CagA into gastric epithelial cells, and 14 cag
genes influence the secretion of IL-8 [21]. Several of these
genes encode products that exhibit low-level sequence similarity
to components found in the T4SSs of A. tumefaciens and other
bacterial species [11,12,14]. At least 9 of the cag genes that are
reported to be required for function of the cag T4SS lack
homologs in other bacterial species [12,21,33]. The functions of
the encoded proteins remain largely uncharacterized. Struc-
tural analyses have been undertaken for several components of
the cag T4SS [17], and several studies have shown that Cag
proteins can interact to form subassemblies [33–36]. Overall,
there is only a very limited understanding of the structural
organization of the cag T4SS apparatus.
Surface-exposed pili are an important feature of T4SSs [28,37].
The T4SS pili of A. tumefaciens are comprised of VirB2 (the major
pilin subunit) and VirB5 (the minor pilin subunit) [28,37]. When
H. pylori is in contact with gastric epithelial cells, the bacteria
express pili that are associated with the cag T4SS [38-41].
Relatively little is known about the composition and biogenesis of
these H. pylori pili. In contrast to T4SS pili from other bacterial
species, the H. pylori T4SS pili are reported to be sheathed
organelles [38]. H. pylori CagC is reported to be a VirB2 homolog
[40], but there is not yet convincing evidence that CagC is a major
component of H. pylori pili. Several of the H. pylori proteins (CagY,
CagT, and CagX) that have been localized to the pili by
immunogold staining [38,41] are distantly related to core complex
components in other T4SS (VirB10, VirB7, and VirB9, respec-
tively). H. pylori CagL has also been localized to pili by
immunogold staining and it is suggested that it is a minor pilus
component [39]; however, CagL and VirB5 do not exhibit any
detectable sequence similarity. Taken together, these findings
suggest that the pili associated with the H. pylori cag T4SS are
considerably different from the T4SS pili of A. tumefaciens and other
known bacterial T4SSs.
CagL is a 26 kDa protein component of the cag T4SS that
lacks homologs in other bacterial species. In various studies,
CagL has been detected as a constituent of the T4SS pilus [39],
on the surface of H. pylori [42], or as a protein localized to the
soluble fraction of H. pylori lysates [38,43]. H. pylori mutants
lacking cagL are defective in the ability to translocate CagA into
host cells and do not stimulate production of IL-8 by gastric
epithelial cells [21,39]. An important feature of CagL is its ability
to bind a5b1 integrin [39]. CagL contains a canonical integrin-
binding RGD motif, but there is not uniform agreement about
the functional significance of this RGD motif in mediating
binding of H. pylori to a5b1 integrin [39,44]. A recent study
reported that recombinantly expressed CagL functionally mimics
fibronectin in its ability to induce focal adhesion formation in
mouse fibroblasts and stimulate spreading of AGS cells [42].
Another study reported that CagL mediates dissociation of
ADAM17 from a5b1 integrin [45]. This leads to NFkB-mediated
repression of the gastric H,K-adenosine triphosphate a-subunit
(HKa), which may ultimately contribute to transient hypochlor-
hydria in H. pylori-infected individuals [45]. Recently it was
reported that, in addition to CagL, three other H. pylori proteins
encoded by the cag PAI (CagA, CagI, and CagY) can interact
with b1 integrin [44]. Interactions of these Cag proteins with b1
integrin have been detected using several approaches, including
yeast two-hybrid screening, analysis of interactions between these
proteins and integrin on the surface of gastric epithelial cells, and
surface plasmon resonance analysis [44].
Since CagL is an important component of the cag T4SS that
interacts directly with epithelial cells, we reasoned that CagL
might physically interact with other T4SS components, and that
such interactions might be required for CagL export, localization,
stability, or activity. In the current study, we report that two other
proteins encoded by the cag PAI (CagH and CagI) co-purify with
CagL, and we provide evidence that these three proteins are
components of one or more subassemblies associated with the cag
T4SS. CagL, CagI, and CagH are not homologous to components
of T4SSs in other bacterial species, but we demonstrate that all
three proteins are essential for activity of the cag T4SS. We show
that all three proteins are detectable on the bacterial surface.
Scanning electron microscopy studies reveal that CagI and CagL
are required for formation of pili at the interface between H. pylori
and gastric epithelial cells, and a DcagH mutant strain produces pili
with a distorted morphology compared to the pili of wild-type
bacteria. This suggests that CagH functions as a regulator of pilus
dimensions. Furthermore, we show that CagH, CagI, and CagL
proteins contain a conserved C-terminal hexapeptide motif that is
critical for T4SS functionality, and in the case of CagI and CagL,
this motif is required for T4SS pilus formation. These studies
highlight the important functions of these unique H. pylori cag
T4SS components and illustrate the marked variation that exists
among bacterial T4SSs.
Author Summary
Helicobacter pylori persistently colonizes the stomach in
approximately half of the human population. People who
are infected with H. pylori strains harboring the cag
pathogenicity island (PAI) have an increased risk of
developing gastric cancer. The cag PAI encodes a type IV
secretion system (T4SS) that is utilized by the bacteria to
inject the bacterial oncoprotein CagA into gastric epithelial
cells. Related T4SSs found in several other bacteria have
been studied in detail, but thus far there has been very
little study of the H. pylori cag T4SS. Here, we utilized a
mass spectrometry-based approach to reveal co-purifica-
tion of three constituents of the H. pylori T4SS (CagH, CagI,
and CagL) that lack homology to components of T4SSs in
other bacterial species. These proteins are essential for
CagA translocation into host cells, and scanning electron
microscope studies reveal that the proteins are involved in
the formation of pili at the bacterial-host cell interface. A
conserved C-terminal motif present in CagH, CagI, and
CagL is essential for functionality of the T4SS. This study
highlights the important role played by unique constitu-
ents of the H. pylori cag T4SS, and illustrates the marked
variation that exists among bacterial T4SSs.
H. pylori Type IV Secretion System
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Identification of Cag Proteins that Co-Purify with CagL
Previous studies have shown that CagL is an important
component of the H. pylori cag T4SS that can bind a5b1 integrin
[21,39,44]. We hypothesized that CagL interacts with other
components of the cag T4SS to form one or more subassemblies.
Therefore, we sought to identify H. pylori proteins that co-purify
with CagL. To facilitate these studies, a cagL-deficient H. pylori
mutant strain (DcagL) was generated as described in Methods. As
expected, CagL expression was detected by immunoblot analysis
in the wild-type (WT) strain but not in the DcagL mutant strain
(Figure 1A). Consistent with previous reports [21,39,44], the DcagL
mutant strain was defective in the ability to stimulate IL-8
secretion by gastric epithelial cells (Figure 1B) and defective in the
ability to translocate CagA into gastric epithelial cells (Figure 1C).
Complementation with an epitope-tagged form of CagL restored
the ability of the bacteria to translocate CagA into host cells and
induce IL-8 secretion (Figure 1A–D).
We used a polyclonal anti-CagL serum to immunoaffinity-
purify CagL from a wild-type H. pylori strain, and a DcagL mutant
strain was processed in parallel. As expected, immunoblotting
studies showed that CagL was immunoaffinity-purified from WT
lysate but not DcagL lysate (data not shown). The protein content
of each sample was analyzed using multidimensional protein
identification technology (MudPIT). Numerous proteins were
detected in each sample, but we focused in particular on proteins
encoded by the cag PAI, since many of these are known or
predicted to comprise components of the cag T4SS. CagL was
identified by MudPIT in the preparation derived from WT lysate,
but was not detected in the preparation derived from DcagL lysate
(Table 1). In addition, the relative abundance of CagH and CagI
peptides detected in affinity-purified preparations derived from the
WT strain was significantly higher than the number of CagH and
CagI peptides detected in preparations derived from the DcagL
mutant strain (Table 1). Peptides identified for CagH, CagI, and
CagL covered 33% to 51% of the respective proteins (Figure 1E).
CagH and CagI co-purified with CagL from the WT strain in six
independent experiments (data not shown). CagA and several
other Cag proteins were also detected in the affinity purified
preparations, but the numbers of spectral counts corresponding to
these proteins were not significantly different when comparing
preparations derived from WT and DcagL mutant strains (Table 1).
Many other Cag proteins were detected by mass spectrometric
analysis of crude bacterial lysate (Table S1), but were not detected
in the affinity purified preparations. These initial experimental
results, demonstrating co-purification of CagL, CagH, and CagI,
suggested that these three proteins are components of one or more
subassemblies associated with the T4SS.
As another approach for identifying proteins that co-purify with
CagL, we undertook experiments with a complemented DcagL
mutant strain expressing CagL with an N-terminal hemagglutinin
(HA) epitope tag (Figure 1D). We immunoaffinity-purified CagL-
HA from lysate of the strain expressing CagL-HA, using an
immobilized monoclonal anti-HA antibody; the WT strain
(expressing CagL without an HA tag) was processed in parallel
in the same manner. CagL-HA and co-purifying proteins were
eluted from the anti-HA affinity column by HA peptide
competition, and MudPIT was utilized to analyze the total protein
content of the samples. Mass spectrometry identified only three
Cag proteins in the sample purified from the strain expressing
CagL-HA: the target protein CagL-HA, CagI, and CagH
(Table 2). The relative abundance of CagL and CagI peptides
detected in the preparation from the CagL-HA-expressing strain
was significantly higher than the number of CagL and CagI
peptides detected in the preparation from the WT strain. Of note,
compared to affinity-purified preparations of CagL obtained using
polyclonal antiserum, the preparation of CagL-HA obtained using
a monoclonal antibody and peptide elution had a much higher
level of purity (Table 2 and Table S2).
To further investigate potential interactions among CagH,
CagI, and CagL, we attempted to generate polyclonal antisera
against CagH and CagI, but this failed to yield antisera that
recognized the corresponding H. pylori proteins. Therefore, we
generated unmarked non-polar DcagH and DcagI mutants
(Figure 2A and B), as well as complemented mutant strains
expressing epitope-tagged forms of CagH or CagI in a
heterologous chromosomal locus (Figure 2C). CagH-HA and
CagI-FLAG proteins of the expected masses were detected in the
complemented bacteria (but not WT bacteria) by immunoblotting
using monoclonal antibodies against the epitope tags (Figure 2D).
We immunoaffinity-purified CagH-HA from lysate of the strain
expressing this protein, and lysate from the WT strain (expressing
CagH without an HA tag) was processed in parallel. The relative
abundance of CagH, CagI and CagL detected in the preparation
from the CagH-HA-expressing strain was significantly higher than
the number of CagH, CagI and CagL peptides detected in the
preparation from the WT strain (Table 2 and Table S2).
In a similar manner, we purified CagI-FLAG from the strain
expressing this epitope-tagged protein. The relative abundance of
CagI, CagH, and CagL detected in the preparation from the
CagI-FLAG-expressing strain was significantly higher than the
number of corresponding peptides detected in the preparation
from the WT strain (Table 2). These experiments recapitulated the
co-purification of CagH, CagI, and CagL that was observed in
initial purifications utilizing polyclonal anti-CagL antisera
(Table 1). In individual experiments, we sometimes detected levels
of other proteins besides CagH, CagI, and CagL that were
significantly increased in affinity-purified preparations compared
to control preparations (Table S2), but these results were not
consistently reproduced and were not recapitulated when alternate
members of a putative CagH-CagI-CagL complex were targeted
for purification.
Further analysis revealed that there is weak sequence similarity
between the amino acid sequences of CagL and CagH (32%
amino acid identity and 47% similarity in the C-terminal region,
Figure 1F). CagL, CagI, and CagH are encoded by contiguous,
overlapping genes in an operon [46] (Figure 1G). Other genes
included in this operon, upstream from cagH, cagI, and cagL,
include cagC (encoding the putative T4SS major pilin component
[40]), cagE (homologous to virB4, encoding an ATPase required for
T4SS function), and cagF (encoding a chaperone protein that binds
to CagA) [47]. Since we observed highly reproducible co-
purification of CagH, CagI, and CagL, and because genes within
an operon often have related functions, we proceeded to undertake
further studies of all three proteins.
CagL Stability is Impaired in the Absence of CagH and
CagI
Previous studies have reported decreased stability of T4SS
components if one or more interacting proteins are absent
[36,37,43,48,49]. Based on the observed co-purification of CagI
and CagH with CagL, we hypothesized that CagL stability might
be impaired in the absence of CagI or CagH. To assess CagL
protein stability, we analyzed bacterial lysates prepared from the
WT strain, DcagI mutant, and DcagH mutant, each cultured for
either 24 h or 48 h. CagL could be detected by immunoblotting of
lysates from all three strains at 24 h of growth (Figure 3A).
H. pylori Type IV Secretion System
PLoS Pathogens | www.plospathogens.org 3 September 2011 | Volume 7 | Issue 9 | e1002237Figure 1. Functional analysis of CagL. (A) Immunoblot (IB) analysis indicates that CagL is expressed in wild-type H. pylori 26695 (WT), but not in
Dcag PAI or DcagL mutants. Complementation of DcagL with a gene encoding an epitope-tagged form of CagL (CagL-HA) results in restoration of
CagL expression. (B) AGS cells were infected with WT H. pylori or the indicated mutants, and levels of IL-8 secreted by AGS cells were quantified by
ELISA. A wild-type strain was able to induce IL-8 secretion, whereas mutants deficient in cagL were unable to induce IL-8 secretion. Complementation
of CagL rescued the ability of DcagL to stimulate IL-8 secretion. Values from six replicate samples were compared to the wild-type control by ANOVA
followed by Dunnett’s post hoc test; # indicates p,0.05. (C) AGS cells were co-cultured with WT H. pylori or the indicated mutants, and tyrosine-
phosphorylated CagA was detected using an anti-phosphotyrosine antibody (a-PY99). Samples also were immunoblotted with an anti-CagA antibody
and antiserum reactive with multiple H. pylori proteins (a-Hp). The DcagL mutant was defective in ability to translocate CagA into AGS cells. (D)
Schematic of a construct encoding an epitope-tagged form of CagL (CagL-HA), used to complement DcagL in cis from the ureA locus. PureAB, ureAB
promoter; cat, chloramphenicol resistance mediated by chloramphenicol acetyltransferase gene of C. coli. (E) CagH and CagI were each co-
immunoaffinity purified with the target protein CagL from WT lysate. CagH, CagI, and CagL peptides identified by MudPIT (pooled data from all CagL
purifications shown in Table 1 and 2) are indicated. N-terminal signal peptides (underlined) are predicted to be present in CagI and CagL, based on
SignalP analysis [82,83]. (F) An alignment of CagH and CagL protein sequences reveals sequence similarity between the C-terminal portion of CagH
and the corresponding portion of CagL (32% amino acid identity, 47% similarity in the region shown). (G) Operon structure of the cag PAI region
spanning from cagA to cagM [46]. Black arrows indicate transcriptional start points. cagH, cagI, and cagL are contiguous genes within an operon
spanning from cagC to cagL and a suboperon spanning from cagF to cagL [46].
doi:10.1371/journal.ppat.1002237.g001
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reduced in lysates from the DcagI and DcagH mutants compared to
levels in WT lysate. CagL stability at the 48 h timepoint was
increased by complementation of the mutant strains (Figure 3A).
We also evaluated the stability of CagL in the absence of two Cag
proteins selected as controls (CagA and CagF). We did not detect
significant co-purification of CagA or CagF with CagL in the
previous experiments (Table 1), and neither CagA nor CagF is
required for functionality of the T4SS, based on analysis of IL-8
induction [21]. Absence of CagA or CagF did not have any
detectable effect on CagL stability during early or late phases of
growth (Figure 3A).
We next investigated the possibility that the observed reductions
in CagL protein expression in DcagH and DcagI mutants might be
attributable to a reduction in cagL transcription. Analysis of cagL
transcription in each of these strains by real-time PCR indicated
that cagL transcription was not diminished, but was in fact
increased in the DcagH and DcagI mutants compared to the WT
strain at 48 h of growth (Figure 3B). Thus, the observed reduction
in CagL levels in the DcagH and DcagI mutant strains is attributed
to reduced stability of CagL, rather than decreased transcription of
cagL.
To further investigate potential relationships among CagL,
CagI, and CagH, we analyzed whether co-purification of CagI
with CagL was dependent on the presence of CagH. We used
polyclonal anti-CagL antiserum to immunoaffinity purify CagL
from both the WT strain and a DcagH mutant strain, each cultured
for 24 h (which permitted stable expression of CagL in both
strains). The samples were then analyzed by mass spectrometry. As
expected, CagL was immunoaffinity purified from both the WT
strain and the DcagH mutant (Table S3). CagI was co-purified
along with CagL from the WT strain, but not from the DcagH
mutant (Table S3). In a similar manner, we investigated whether
co-purification of CagH with CagL was dependent on the
presence of CagI. CagH was co-purified with CagL from both
the WT strain and DcagI mutant; however, significantly lower
levels of CagH were co-purified from the DcagI mutant strain
(Table S3).
In summary, these experiments indicate that CagL stability is
reduced in the absence of CagH or CagI, and co-purification of
CagH or CagI with CagL is dependent on the presence of all three
proteins. Taken together with the previous results (Table 1 and 2),
these data provide evidence that CagL, CagI, and CagH are
components of one or more subassemblies associated with the cag
T4SS.
Functional Properties of CagH and CagI
A previous study, which analyzed mutant strains containing
transposon insertions in individual cag genes, provided an
important foundation for identifying genes in the cag PAI that
are required for functionality of the H. pylori cag T4SS [21]. This
study reported that both CagH and CagI were required for CagA
translocation, and that CagH (but not CagI) was required for IL-8
induction [21]. A limitation of the methodologic approach was
that unrecognized spontaneous secondary mutations or polar
effects associated with transposon insertion into the cag PAI could
not be confidently excluded. To determine definitively whether
CagH and CagI were required for the function of the cag T4SS, we
analyzed the unmarked DcagH and DcagI deletion mutant strains
and complemented mutants described in the previous section.
In comparison to the WT strain, both the DcagH and DcagI
mutants were defective in their ability to induce IL-8 secretion in
gastric epithelial cells (Figure 2E). Complementation of these
mutants with genes encoding CagH-HA and CagI-FLAG,
respectively, rescued the ability of the DcagH and DcagI mutants
to induce IL-8 secretion at WT levels (Figure 2E). Immunoblot
analysis indicated that CagL remained intact in the mutant strains
throughout the assay (Figure 2E), which indicates that the inability
of these mutant strains to induce IL-8 expression is attributable to
absence of either CagH or CagI, respectively, rather than
Table 1. Cag proteins that co-purify with CagL.
a-CagL
b
Gene Number
a Protein WT DcagL WT DcagL
HP0539 CagL 19
** 02 1
*** 0
HP0540 CagI 33
*** 02 9
*** 0
HP0541 CagH 17
** 01 9
*** 0
HP0547 CagA 33 13 32 27
HP0522 Cag3 2 0 0 0
HP0527 CagY 4 1 3 3
Total Spectral Counts 3009 1054 2829 2609
aBased on the H. pylori 26695 genome annotation.
bCagL was affinity purified from the WT strain (cultured for 48 h) using anti-
CagL polyclonal antiserum, and a DcagL mutant was processed in parallel as a
control. The Table shows numbers of spectral counts observed by MudPIT
analysis for each identified Cag protein. The Table shows results from two
independent experiments.
**p,0.01; *** p,0.001 when comparing WT with the DcagL mutant, according
to the G-test likelihood ratio, post-spectral count normalization.
doi:10.1371/journal.ppat.1002237.t001
Table 2. Cag proteins that co-purify with epitope-tagged
CagH, CagI, and CagL.
a-HA
b a-FLAG
c
Gene Number
a Protein WT
CagH-
HA
CagL-
HA WT CagI-FLAG
HP0540 CagI 0 203 *** 10
*** 01 7 0
***
HP0541 CagH 1 91 *** 2 0 19
***
HP0539 CagL 0 98 *** 21 *** 0 19
***
HP0547 CagA 0 2 0 47 87
HP0544 CagE 0 0 0 6* 1
HP0535 CagQ 1 4 0 0 0
HP0530 CagV 0 0 0 4 4
HP0543 CagF 0 0 0 2 2
HP0528 CagX 0 0 0 2 6
HP0527 CagY 0 0 0 5 4
HP0520 Cag1 0 0 0 3 2
Total Spectral
Counts
208 1428 237 6310 10942
aBased on the H. pylori 26695 genome annotation.
bCagH-HA or CagL-HA were affinity purified from strains expressing these
proteins using an anti-HA antibody, and a WT strain was processed in parallel
as a control. The Table shows numbers of spectral counts observed by MudPIT
analysis for each identified Cag protein.
cCagI-FLAG was affinity purified from a strain expressing this protein using an
anti-FLAG antibody, and a WT strain was processed in parallel as a control. The
Table shows numbers of spectral counts observed by MudPIT analysis for each
identified Cag protein.
*p,0.05; *** p,0.001 when compared to WT control, according to the G-test
likelihood ratio, post-spectral count normalization.
doi:10.1371/journal.ppat.1002237.t002
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PLoS Pathogens | www.plospathogens.org 5 September 2011 | Volume 7 | Issue 9 | e1002237Figure 2. Functional analysis of CagH and CagI. (A) A metronidazole-resistant (Met
R) strain of H. pylori was generated by transforming the WT
strain with pMM672 (p-DrdxA); metronidazole-resistant transformants contained a deletion of the rdxA locus. The cagI chromosomal locus was
deleted by transforming the metronidazole-resistant H. pylori with p-cagI::rdxA/cat; this resulted in chloramphenicol-resistant (Cat
R), metronidazole-
sensitive (Met
S) colonies, designated cagI::rdxA/cat. To generate a mutant containing an unmarked cagI deletion, H. pylori cagI::rdxA/cat was
transformed with pDcagI5-1, and metronidazole-resistant colonies were selected. (B) Schematic illustration of the chromosomal cagH-cagI-cagL
region in the WT strain, cagI::rdxA-cat mutant, and DcagI unmarked mutant. A similar approach was used to generate an unmarked DcagH mutant
strain. (C) Schematic of plasmids encoding epitope-tagged forms of CagH and CagI. PureAB, ureAB promoter; cat, chloramphenicol resistance
mediated by chloramphenicol acetyltransferase gene of C. coli. The hemagglutinin (HA) epitope sequence was inserted into CagH at the N-terminus
(CagH-HA), and the FLAG epitope was inserted at residue 51 of CagI (CagI-FLAG). Numbers indicate position of residues in the epitope tagged
proteins. These plasmids were introduced into DcagH and DcagI mutants, respectively, and the resulting complemented strains contained sequences
encoding CagH-HA or CagI-FLAG, inserted into the ureA locus. (D) Immunoblot analysis of CagH-HA and CagI-FLAG in the complemented DcagH and
H. pylori Type IV Secretion System
PLoS Pathogens | www.plospathogens.org 6 September 2011 | Volume 7 | Issue 9 | e1002237instability of CagL. The DcagH and DcagI mutants were also
defective in their ability to translocate CagA into gastric epithelial
cells (Figure 2F). The ability of these mutants to translocate CagA
at levels comparable to WT was rescued by complementation with
epitope-tagged versions of the corresponding proteins (Figure 2F).
These results indicate that CagH and CagI, similar to CagL, are
required for proper function of the cag T4SS.
Localization of CagH, CagI, and CagL
Since expression of CagH and CagI proteins in H. pylori has not
been detected previously, we sought to analyze the subcellular
localization of these proteins. As a first approach, we investigated
potential surface exposure of CagH, CagI, and CagL by analyzing
the susceptibility of these proteins, as well as several controls, to
digestion by proteinase K. As expected, incubation of the intact
bacteria with proteinase K was sufficient to cleave VacA, a protein
known to be localized on the bacterial surface [50,51] (Figure 4A).
In contrast, carbonic anhydrase (CA), a protein known to have a
periplasmic domain [52], was not susceptible to cleavage by
proteinase K. Similarly, CagV (a VirB8 homolog), which is
predicted to have domains in the periplasmic space [16,17,43],
was also resistant to cleavage by proteinase K (data now shown).
CagH-HA, CagI-FLAG, and CagL-HA were each susceptible to
cleavage by proteinase K (Figure 4A), but in contrast to VacA,
these three Cag proteins were incompletely digested. This suggests
that CagH, CagI, and CagL are present on the bacterial surface,
and in addition, another pool of these proteins exists in a site that
is not susceptible to the protease. Consistent with the susceptibility
of CagH-HA, CagI-FLAG, and CagL-HA to cleavage by
proteinase K, surface exposure of all three proteins was detected
by flow cytometry analysis (Figure 4B). Immunogold labeling
studies also revealed localization of CagH-HA, CagI-FLAG, and
CagL-HA on the surface of H. pylori (Figure 5). Typically fewer
than 10 gold particles per bacterial cell were visualized on the
peripheral margins of bacteria, which suggests either that the
number of CagH, CagI, and CagL proteins on the bacterial
surface under these conditions is relatively small, or that there may
be limitations with the use of these monoclonal antibodies for
immunogold labeling.
As another approach for analyzing the subcellular localization
of CagH, CagI, and CagL, H. pylori strains expressing CagH-HA,
CagI-FLAG, or CagL-HA were sonicated and fractionated in the
absence of detergent. Soluble fractions (which are expected to
contain cytoplasmic and periplasmic proteins) and total membrane
fractions were analyzed by immunoblotting using monoclonal
antibodies directed against the appropriate epitope tags. In
DcagI mutant strains, using monoclonal antibodies directed against the epitope tags. (E) WT H. pylori or the indicated mutants were co-cultured with
AGS cells for 4.5 h, and IL-8 expression was analyzed by ELISA. DcagH and DcagI mutants were defective in ability to induce IL-8 secretion, and
complementation corrected the defect. Values from six replicate samples were compared to the wild-type control by ANOVA followed by Dunnett’s
post hoc correction; # indicates p,0.05. CagL remained detectable in all strains throughout the assay, as demonstrated by anti-CagL immunoblot
(inset). (F) AGS cells were co-cultured with WT H. pylori or the indicated mutants, and tyrosine-phosphorylated CagA was detected with an anti-
phosphotyrosine antibody (a-PY99). Samples also were immunoblotted with an anti-CagA antibody and antiserum reactive with multiple H. pylori
proteins (a-Hp). CagA translocation was impaired in the DcagH and DcagI mutants.
doi:10.1371/journal.ppat.1002237.g002
Figure 3. Analysis of CagL expression in DcagH and DcagI mutants. (A) H. pylori strains were cultured for 24 or 48 hours on solid media prior
to lysis and immunoblotting to detect expression of CagL. Expression of HspB, a heat shock protein homolog, was analyzed as a control. In the DcagH
and DcagI mutants, levels of CagL were markedly lower at the 48 h timepoint than at the 24 h timepoint. CagL levels remained stable at both
timepoints in the WT strain and the complemented mutants expressing CagH-HA or CagI-FLAG. CagL stability is unaffected by absence of Cag
proteins that do not interact with CagL (DcagA and DcagF). (B) RT-PCR analysis of cagH, cagI, and cagL transcription in the indicated WT and mutant
bacteria, cultured for 48 h. cagL transcript levels are upregulated in the DcagH and DcagI mutants, compared to levels detected in the WT strain. #
indicates p,0.05 according to one-way ANOVA with Dunnett’s post hoc correction.
doi:10.1371/journal.ppat.1002237.g003
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was localized mainly in the soluble fraction, and lesser amounts
were present in the membrane fraction; similar results were
observed for CagL-HA (Figure 4C, D, E). Both CagH-HA and
CagI-FLAG were localized exclusively in the membrane fraction
(Figure 4D, E). The insolubility of CagH and CagI in this
experiment compared to previous experiments is attributed to the
absence of detergent in these fractionated samples and the
presence of detergent in earlier samples. We propose that, when
complexed together, CagL is loosely tethered to membrane-
associated CagH and CagI, and that in the absence of detergent,
the shear forces or heat generated by sonication are sufficient to
disrupt this interaction and solubilize CagL, but not CagH and
CagI. An additional possibility is that the CagH-CagI-CagL
complexes include the relatively small portion of membrane-
associated CagL.
In summary, these experiments provide evidence that CagL,
CagH, and CagI exist in multiple subcellular locations, including
the surface of H. pylori. The existence of these proteins in multiple
subcellular locations potentially reflects multiple stages of T4SS
assembly. Localization of CagL mainly to the soluble fraction as
well as on the bacterial surface helps to reconcile apparent
contradictions in previous publications, which reported CagL
localization to either the soluble fraction or surface-exposed sites
Figure 4. Localization of CagH and CagI. (A) Whole bacteria expressing CagL-HA, CagH-HA, or CagI-FLAG were harvested after 24 h of growth
and subjected to proteolytic digestion with Proteinase K (PK). Susceptibility to cleavage by Proteinase K was monitored by immunoblotting using
antibodies against the appropriate epitope tags. As a control, cleavage of VacA (a surface-exposed protein) and carbonic anhydrase (CA, an inner
membrane protein with a periplasmic domain) was monitored. Heat shock protein (HspB) served as a loading control, and densitometry was
performed as described in Methods. Numbers above bands representing CagL-HA, CagH-HA, and CagI-FLAG indicate the percent of protein
remaining after cleavage by PK. (B) Flow cytometry analysis indicates that CagL-HA, CagH-HA, and CagI-FLAG proteins are detectable on the bacterial
surface. (C) Bacteria expressing epitope-tagged CagL (CagL-HA), (D) CagH (CagH-HA), or (E) CagI (CagI-FLAG) were fractionated into total membrane
(M) and soluble (S) fractions as described in Methods. CagL-HA, CagH-HA, CagI-FLAG, and untagged CagL were detected by immunoblotting. As a
control, fractions were immunoblotted with a monoclonal antibody that recognizes an H. pylori outer membrane protein (a-OMP) (Santa Cruz).
doi:10.1371/journal.ppat.1002237.g004
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propose that CagL exists mainly in a periplasmic pool, but it can
also be associated with the outer membrane, perhaps loosely
tethered to the cell surface. Distribution of at least two other Cag
proteins (Cag3 and CagY) into multiple pools with different
localizations has been suggested previously [33,38]. Complexes
comprised of CagH, CagI, and CagL could potentially exist in
multiple sites, including the bacterial surface and the periplasm
(where periplasmic CagL may interact with membrane-associated
CagH and CagI proteins).
CagH, CagI, and CagL have Key Roles in T4SS Pilus
Formation
To investigate a possible mechanism by which CagH, CagI, and
CagL might contribute to activity of the cag T4SS, we used
scanning electron microscopy (FESEM) to analyze interactions of
H. pylori with AGS gastric epithelial cells. Specifically, we tested the
hypothesis that CagH, CagI, or CagL might be required for
formation of pili at the bacterial-host cell interface. As expected,
we detected pili at the interface between WT H. pylori and AGS
cells (Figure 6A), and consistent with previous reports [38,39,41],
these pili were not visualized when a Dcag PAI mutant (Figure 6B),
cagT (virB7 homolog) mutant, or cagE mutant (data not shown) was
co-cultured with AGS cells. Adherent WT bacteria exhibited pili
on surfaces that were contiguous to the epithelial cells, and we did
not observe pili on non-adherent bacteria. The dimensions of the
pili were approximately 14 nm in width and 65 nm in length
(Table 3), and the pili were distributed along the lateral and polar
surfaces of the bacteria. When co-cultured with AGS cells, neither
the DcagL nor the DcagI mutant strains produced detectable pili
(Figure 6C, F). This defect was rescued by complementation of the
DcagI and DcagL mutants (Figure 6D, E, G).
In contrast to the DcagI and DcagL mutant strains, the DcagH
mutant strain was capable of producing pili. However, there were
several striking differences when comparing the DcagH mutant
strain (Figure 7B, C, D, F) with the WT strain (Figure 7A, E). First,
the number of pili produced by the DcagH mutant was significantly
higher than the number of pili produced by the WT strain
(8.064.3 vs. 3.862.6 visible pili per adherent bacteria, p,0.0001)
(Table 3). Second, the length of pili produced by the DcagH mutant
was significantly greater than that of pili produced by the WT
strain (115.1665.1 nm vs. 65.1630.7 nm, p,0.0001). Third, the
width of pili produced by the DcagH mutant was significantly
greater than that of pili produced by the WT strain (21.564.3 nm
vs. 13.762.4 nm, p,0.0001). A complemented DcagH mutant
strain produced pili that were indistinguishable from the pili
produced by the WT strain (Figure 7G and Table 3). These results
suggest that CagH is a regulator of pilus dimensions. As considered
further in the Discussion, an analysis of highly conserved domains
within CagH (Figure 7H) provides clues into possible mechanisms
by which CagH controls dimensions of the H. pylori T4SS pilus.
In all of the initial experiments (Tables 1, 2, and S2),
interactions among CagH, CagI, and CagL were detected in H.
pylori that were cultured in the absence of gastric epithelial cells.
Our electron microscopy experiments indicate that pili associated
with the cag T4SS are not detected when the bacteria are cultured
in the absence of gastric epithelial cells (data not shown), and in
agreement with previous reports [38,39], we found that contact of
H. pylori with gastric epithelial cells stimulates the formation of pili
that are associated with the cag T4SS. This suggests that the cag
Figure 5. Immunoelectron microscopy analysis of whole bacterial cells. H. pylori strains were grown on blood agar plates and immunogold
labeling was performed as described in Methods. (A) DcagH/CagH-HA, stained with anti-HA and gold-labeled secondary antibody. (B) DcagI/CagI-
FLAG, stained with anti-FLAG and gold-labeled secondary antibody. (C) DcagL/CagL-HA, stained with anti-HA and gold-labeled secondary antibody.
(D) WT, stained with anti-HA and gold-labeled secondary antibody. (E) WT, stained with anti-FLAG and gold-labeled secondary antibody. (F) WT,
stained with secondary antibody only (representative image for all strains when treated with secondary antibody only). Magnification bars indicate
100 nm. Arrowheads indicate location of gold-labeled secondary antibody.
doi:10.1371/journal.ppat.1002237.g005
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absence of gastric epithelial cells. To determine whether
interactions among CagH, CagI, and CagL are detectable under
conditions in which the cag T4SS is fully assembled, we sought to
detect the presence of this subassembly in H. pylori that were co-
cultured with gastric epithelial cells. We co-cultured bacteria
expressing CagH-HA with AGS cells, affinity purified CagH-HA
from adherent bacteria, and then analyzed the protein content of
the affinity purified preparation. Wild-type bacteria were co-
cultured with AGS cells and were processed in parallel as a
control. As shown in Table S4, we again observed co-purification
of CagH, CagI, and CagL. Therefore, a CagH-CagI-CagL
subassembly is detectable not only when bacteria are cultured in
the absence of gastric epithelial cells, but also under conditions in
which the cag T4SS is fully assembled.
Since CagL was previously detected as a pilus component [39],
we hypothesized that CagI and CagH might also localize to pili.
To test this hypothesis, we used scanning EM and immunogold
labeling studies to analyze H. pylori that were co-cultured with
gastric epithelial cells. Using this approach, we were unable to
detect localization of CagH or CagI to the pili, and we were also
unable to detect CagH or CagI in any other sites. Since we were
able to detect surface localization of CagH, CagI, and CagL in
transmission EM experiments and flow cytometry experiments but
not FESEM experiments, there are probably limitations associated
with the use of these monoclonal antibodies for immunogold
Figure 6. Role of CagI and CagL in pilus formation. WT H. pylori, mutant strains, and complemented mutant strains were co-cultured with AGS
cells and then analyzed by FESEM. (A) WT. (B) Dcag PAI. (C) DcagL. (D) DcagL/CagL-HA. (E) High magnification of pilus structures produced by
DcagL/CagL-HA (panel D). (F) DcagI. (G) DcagI/CagI. Arrowheads indicate T4SS pilus structures. Magnification bars indicate 200 nm.
doi:10.1371/journal.ppat.1002237.g006
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methodology requires multiple extra washing steps (a series of
seven sequential ethanol dehydration steps and three liquid carbon
dioxide washing steps) that are not required for transmission EM,
and monoclonal antibodies often are considered suboptimal
compared to polyclonal antisera for immunogold EM studies [53].
Analysis of a Conserved C-terminal Motif
Careful inspection of the sequences of CagH, CagI, and CagL
revealed that all three proteins contain a conserved C-terminal
motif (Figure 8A) consisting of the distal six amino acids of each
protein. The C-terminal motifs of CagH, CagI, and CagL are
encoded by divergent DNA sequences (Figure 8A). To investigate
whether this C-terminal motif is functionally important, we
generated H. pylori mutant strains expressing forms of CagH,
CagI, or CagL in which this hexapeptide motif was deleted, as
described in Methods. Deletion of the C-terminal motif individ-
ually in CagH, CagI, and CagL resulted in reduced levels of the
mutated proteins compared to levels of the corresponding WT
proteins (Figure 8B), along with a marked reduction in ability of
the mutant bacteria to induce IL-8 secretion by AGS cells
(Figure 8C) and abolishment of CagA translocation (Figure 8D). In
contrast to wild-type CagH-HA and CagI-FLAG, which each
localize to the membrane fraction (Figures 4 and 8E), CagH-
HADCT and CagI-FLAGDCT are partially mislocalized to the
soluble fraction (Figure 8E). Furthermore, in the absence of the C-
terminal motif of CagH-HA or CagI-FLAG, CagL stability is
markedly reduced at the 48 h growth timepoint compared to
CagL stability at the 24 h growth timepoint (Figure 8F). This result
further supports the conclusion that CagH, CagI, and CagL are all
members of a protein subassembly.
Finally, we conducted experiments to determine whether the
C-terminal motifs found in CagH, CagI, and CagL were
required for formation of pili at the interface between H. pylori
and gastric epithelial cells. Mutant strains lacking the C-terminal
motif in CagH, CagI, or CagL were co-cultured with AGS cells,
and the samples were then analyzed by FESEM. Bacteria
expressing CagI-FLAGDCT or CagLDCT each failed to
produce detectable pili (Figure 9C, D), and thus had a phenotype
indistinguishable from DcagI and DcagL mutants (Figure 6).
Bacteria expressing CagH-HADCT expressed pili that were
indistinguishable from those produced by the WT strain
( F i g u r e9 A ,Ba n dT a b l e3 ) .D e s p i t ep r o d u c i n gn o r m a l -
appearing pili, the CagH-HADCT mutation rendered the cag
T4SS non-functional (Figure 8C, D). These experiments indicate
that physical contact of these H. pylori pili with the AGS cell
surface is not sufficient to induce IL-8 production, and indicate
that the C-terminal motif present in CagH, CagI, and CagL is
critical for functionality of the T4SS.
Discussion
One of the important mechanisms by which H. pylori infection
leads to severe gastric disease is through the actions of the bacterial
oncoprotein CagA [4,10,11,54]. Translocation of CagA into
gastric epithelial cells occurs through a T4SS-mediated process
and requires multiple proteins encoded by the cag PAI [12,14–
17,21]. Several H. pylori proteins required for CagA translocation
are distantly related to components of T4SSs in other bacterial
species and presumably have conserved functions [12,21,28,43].
In the current study, we provide new insights into three
components of the cag T4SS that lack homologs in other T4SSs
– CagH, CagI, and CagL.
Prior to the current study, it was known that CagL can bind
a5b1 integrin and can cause several alterations in host cells
[21,39,42,44,45]. CagL was localized in various studies to several
bacterial subcellular sites, including a soluble bacterial fraction
[38,43], the bacterial surface [42], and pili on the surface of H.
pylori [39] We reasoned that CagL might physically interact with
other T4SS components, and that such interactions might be
required for CagL export, localization, stability, or activity.
Therefore, we conducted studies designed to identify H. pylori
proteins that interact with CagL. In initial experiments involving
affinity purification of CagL, we observed a highly reproducible
co-purification of CagH and CagI with CagL, and we subse-
quently detected the same pattern of co-purification when either
CagH or CagI was targeted for purification. We detected evidence
of CagH-CagI-CagL interactions not only in experiments
involving bacteria grown in pure culture, but also in experiments
involving H. pylori that were attached to gastric epithelial cells. We
were unable to undertake analysis of direct interactions among
CagL, CagI and CagH because recombinant CagI and CagH
could not be expressed in a soluble form under non-denaturing
conditions. However, several other results provided evidence of a
physical relationship among these proteins. Specifically, CagL
stability was decreased in the absence of either CagI or CagH, and
co-purification of CagI or CagH with CagL was dependent on the
presence of all three proteins. All three proteins are required for
functional activity of the cag T4SS, and all three proteins have a
role in formation of pili at the interface between H. pylori and
gastric epithelial cells. Other intriguing relationships among these
proteins include their linkage within a single operon in the cag PAI
[46], ability of both CagI and CagL to bind b1 integrin [39,44],
and presence of a nearly identical C-terminal motif in all three
proteins. Collectively, the data suggest that CagL, CagI, and
CagH are components of one or more T4SS subassemblies
involved in pilus biogenesis.
Recognition of the relationships among CagH, CagI, and CagL
in the current study was facilitated by using immunoaffinity
purifications and a robust multidimensional mass spectrometry
protein identification technique. In comparison to traditional co-
immunoprecipitation experiments, which rely upon the availability
of antibodies to detect potential interacting partners of a target
protein by immunoblotting, the mass spectrometry-based ap-
proach used in the current study allowed a comprehensive analysis
that was not limited by the availability of antibodies. In addition,
this approach affords advantages compared to two-hybrid screens,
because it allows detection of interactions among native proteins
expressed in H. pylori, as well as the potential to detect indirect
secondary and tertiary interactions. Analysis of the appropriate
Table 3. Analysis of type IV secretion system pili.
Width (nm)
a Length (nm)
a Pili/cell
a
WT 13.762.4 65.1630.7 3.862.6
DcagH 21.564.3
*** 115.1665.1
*** 8.064.3
***
DcagH/CagH-HA 14.462.8 65.6629.9 3.362.9
DcagH/CagH-HADCT 15.865.1 53.4618.5 3.562.7
DcagI/CagI 15.763.8 91.1646.1 3.161.7
DcagL/CagL-HA 14.662.8 81.7627.2 3.862.8
aQuantification of pilus width, length, and number is based on a minimum of 2
biological replicates and a minimum of 5 representative micrographs
containing a total of at least 20 adherent H. pylori cells.
***, p,0.001 compared to WT, based on two-tailed T-test analysis.
doi:10.1371/journal.ppat.1002237.t003
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PLoS Pathogens | www.plospathogens.org 11 September 2011 | Volume 7 | Issue 9 | e1002237Figure 7. Analysis of pili formed by a DcagH mutant strain. WT H. pylori,aDcagH mutant, and a complemented mutant (DcagH/CagH-HA)
were co-cultured with AGS cells and then analyzed by FESEM. (A) WT strain. (B, C, D) Multiple images of the DcagH mutant. (E) High magnification
of panel A (WT strain). (F) High magnification of panel B (DcagH mutant). (G) DcagH/CagH-HA. Magnification bars indicate 200 nm. (H) Use of a
position-specific scoring matrix (PSSM) within the NCBI Conserved Domain Database [57] identified a conserved flagellar hook protein K (FlgK)
domain in CagH. The alignment compares the region of CagH corresponding to the FlgK domain with sequences of Burkholderia spp. FlgK and
sequences of two members of the flagellar hook superfamily that function as molecular rulers (FliK from Salmonella and YscP from Yersinia pestis)
[59,60,61,64]. Arrows above the alignment indicate three portions of the FlgK domain identified in CagH.
doi:10.1371/journal.ppat.1002237.g007
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PLoS Pathogens | www.plospathogens.org 12 September 2011 | Volume 7 | Issue 9 | e1002237Figure 8. Analysis of a conserved C-terminal motif in CagH, CagI, and CagL. (A) A conserved hexapeptide C-terminal motif is present in
CagH, CagI, and CagL (WebLogo [84]). Numbers indicate positions of amino acid residues relative to the C-terminus of CagH, CagI, or CagL. This C-
terminal motif is encoded by divergent DNA sequences in cagH, cagI, and cagL. (B) Immunoblot analysis of mutants expressing C-terminally
truncated forms of CagL, CagH-HA, or CagI-FLAG, each lacking a six-residue C-terminal motif. CagLDCT was expressed from the endogenous cagL
locus in the cag PAI, and CagH-HADCT and CagI-FLAGDCT were expressed from the ureA locus. CagL expression was detected with anti-CagL serum,
CagH-HA expression was detected with an anti-HA monoclonal antibody, and CagI-FLAG expression was detected with an anti-FLAG antibody.
Truncated forms of CagL, CagH, and CagI were detected in each of the mutant strains, but the levels of the truncated proteins were reduced
compared to levels of the full-length proteins. (C) AGS cells were co-cultured with WT H. pylori or the indicated mutants, and IL-8 expression was
analyzed by ELISA as described in Methods. Values from six replicate samples were compared to the wild-type control by ANOVA followed by
Dunnett’s post hoc correction; # indicates p,0.05. (D) AGS cells were co-cultured with WT H. pylori or the indicated mutants, and tyrosine-
phosphorylated CagA was detected with an anti-phosphotyrosine antibody (a-PY99). (E) Bacteria expressing CagH-HA, a C-terminally truncated form
of CagH-HA (CagH-HADCT), CagI-FLAG, or a C-terminally truncated form of CagI (CagI-FLAGDCT) were fractionated into total membrane (M) and
soluble (S) fractions as described in Methods, and the tagged proteins were detected by immunoblotting. Intact CagH-HA and CagI-FLAG proteins
were detected mainly in the membrane fraction. Deletion of the C-terminal motif from CagH-HA (CagH-HADCT) or CagI (CagI-FLAGDCT) results in
partial mislocalization of these proteins to the soluble fractions. (F) Bacteria expressing C-terminally truncated CagH (CagH-HADCT) or CagI (CagI-
FLAGDCT) were cultured for 24 or 48 h prior to lysis and immunoblotting to detect CagL. HspB was monitored as a loading control. At the 48 h
timepoint, CagL levels are markedly reduced in strains expressing truncated CagH or CagI, compared to strains expressing full-length proteins.
doi:10.1371/journal.ppat.1002237.g008
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interactions and statistical evaluation of results.
Prior to the current study, CagH and CagI had not been
investigated in detail. Neither CagH nor CagI was detected in
analyses of H. pylori using 2D gel proteomic methodology [35,55],
and immunologic detection of CagI expression has been hindered
by difficulty in raising antibodies against the protein [44].
Similarly, our efforts to raise polyclonal antisera against CagH
or CagI proteins failed to yield antisera that recognized the
appropriate antigens. However, we were able to detect CagH and
CagI expression by mass spectrometry, and we were also able to
detect epitope-tagged forms of these H. pylori proteins. One study
reported that CagI was capable of binding b1 integrin in a yeast
two hybrid assay, and CagI interactions with integrin were
confirmed by analyzing binding of a CagI-GST fusion protein to
cell lines deficient in b1 integrin expression or cell lines that had
been genetically complemented with human b1 integrin [44].
Another study reported that H. pylori mutant strains containing
transposon insertions in cagH or cagI were defective in their ability
to translocate CagA into host cells, and that CagH (but not CagI)
was required for induction of IL-8 synthesis and secretion by
cultured gastric epithelial cells [21]. In the current study, we found
that cagH and cagI mutant strains were defective in both CagA
translocation and IL-8 induction. The discrepancy in results
pertaining to CagI and IL-8 induction might be attributable to
differences in the mutagenesis methods utilized to generate DcagI
isogenic mutants. In the current study, we analyzed unmarked
strains containing deletions of the relevant cag genes, and
complementation of the unmarked mutants confirmed that CagH
and CagI are required for CagA translocation and stimulation of
IL-8 secretion by cultured gastric epithelial cells.
Localization analyses performed in the current study indicated
that CagH, CagI, and CagL can all be exported to the surface of
H. pylori, and in addition, provided evidence for the existence of
non-surface-exposed pools of these proteins. The existence of these
proteins in multiple subcellular locations potentially reflects
multiple stages of T4SS assembly. Detection of CagL on the
surface of H. pylori in the current study agrees with previous
reports, which reported localization of CagL to either the bacterial
surface or to pilus structures, based on immunogold EM staining
[39,42]. Other lines of evidence supporting a surface-exposed
localization of CagI and CagL include the ability of both proteins
to bind b1 integrin [39,44], signatures of positive selection in the
genes encoding these two proteins [56], and the presence of a
predicted signal sequence in both proteins (Figure 1E). The
detection of a non-surface-exposed pool of CagL in the current
study agrees with results of previous studies, which detected CagL
in a soluble bacterial fraction consistent with the periplasm
[38,43].
Determining the subcellular location where CagH, CagI, and
CagL assemble into complexes is complicated by the presence of
these proteins in multiple subcellular sites. All three proteins can
localize to the bacterial surface, and this is one site where the
formation of CagH-CagI-CagL complexes may be relevant. In
addition, since a large proportion of CagL is localized to a soluble
fraction, it seems likely that periplasmic CagL may interact with
Figure 9. The C-terminal motif of CagI and CagL is required for pilus formation. WT H. pylori or mutant strains expressing C-terminally (CT)
truncated forms of CagH, CagI, or CagL were co-cultured with AGS cells and imaged by FESEM. (A) WT. (B) CagH-HADCT. (C) CagI-FLAGDCT. (D)
CagLDCT. Magnification bars indicate 200 nm.
doi:10.1371/journal.ppat.1002237.g009
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in the periplasm. We detected evidence of CagH-CagI-CagL
complexes not only in pure bacterial cultures, but also in co-
cultures of H. pylori with gastric epithelial cells (Tables 1, 2, S4).
Since the CagH-CagI-CagL complexes were detected in pure
bacterial cultures (which lack detectable surface pili), the
complexes must clearly be localized to sites distinct from pili
under these conditions. A previous study used immunogold
labeling methods and a polyclonal antiserum to detect localization
of CagL to pilus structures [39]. In the current study, we were not
able to detect localization of CagH or CagI to pilus structures,
probably due to limitations associated with the use of monoclonal
antibodies for immunogold labeling in the context of scanning
electron microscopy. Specifically, the FESEM methodology
requires multiple extra washing steps (a series of seven sequential
ethanol dehydration steps and three liquid carbon dioxide washing
steps) that are not required for transmission EM, and monoclonal
antibodies often are considered suboptimal compared to poly-
clonal antisera for immunogold EM studies [53]. Therefore, at
present it is not known whether CagL localization to pili requires
dissociation of CagL from CagH and CagI, or whether all three
proteins eventually localize to pili.
An important finding in the current study is the demonstration
that both CagL and CagI are required for formation of pili.
Complementation of DcagL and DcagI mutant strains resulted in
restoration of pilus formation and T4SS function. In previous
studies, CagY, CagT, and VirB11 ATPase were reported to be
required for formation of pili [38,39,41], but the role of these
proteins in H. pylori pilus formation has not yet been verified by
testing of complemented mutant strains. CagT, CagY, and the
VirB11 ATPase are each homologous to proteins found in T4SSs
of other bacteria, but in contrast, CagI and CagL do not have
homologues in other T4SSs.
Interestingly, a DcagH mutant strain was hyperpiliated and
expressed pili that were elongated and thickened in comparison
to pili of the WT strain. The increased number of pili visualized
in images of the DcagH mutant strain might be attributable to
their increased thickness and decreased fragility, resulting in a
greater likelihood that the structures are preserved and visualized.
Complementation of the DcagH mutant strain resulted in
production of pili with a WT morphology. These results suggest
that CagH is a regulator of pilus dimensions. Analysis of the
CagH sequence using a conserved domain database search [57]
(NCBI) indicates that it contains a flagellar hook-associated
protein (FlgK) domain (PRK06945) (Figure 7H). The FlgK
domain within CagH is most closely related to the corresponding
domains found in FlgK proteins of Burkholderia spp., rather than
the corresponding domain found in H. pylori FlgK. The FlgK
domain in CagH also exhibits similarity to portions of the FliK
flagellar protein of Salmonella and the YscP type III secretion
system protein of Yersinia pestis (Figure 7H), two proteins that are
known to be determinants of either flagellar hook length [58-63]
or type III secretion system needle length [64]. We speculate that,
analogous to the role of FlgK (a flagellar hook-junction protein) in
terminating flagellar hook assembly, CagH may have a role in
terminating pilus assembly. Alternatively, analogous to FliK and
YscP, CagH may serve as a molecular ruler to control the
dimensions of cag T4SS pili in H. pylori.I tw i l lb ei m p o r t a n ti n
future studies to dissect the molecular mechanisms by which
CagH regulates pilus dimensions.
Similar to previous studies [38-41], we observed that H. pylori
contact with gastric epithelial cells stimulated the production of
pili, and in agreement with previous studies [39,41], we observed
that Dcag PAI mutant, cagT mutant, and cagE mutant strains failed
to produce pili. However, the dimensions of the pili visualized in
the current study differed from what was reported previously.
Specifically, a previous study [38] reported that the pili were
between 45 and 75 nm in width, depending on presence or
absence of a sheath structure, whereas in the current study, we
found that the pili were much thinner. The same strain of H. pylori
was used in both studies, so this difference is probably not
attributable to strain-dependent variation. We speculate that the
difference in reported dimensions might be attributable to
differences in methods for scanning EM, such as the use of a
relatively thin layer of gold in the current study and a thicker layer
of coating in the previous study.
A striking feature shared by CagH, CagI, and CagL is a
conserved C-terminal hexapeptide motif (Figure 8A). This C-
terminal motif is not found in any other protein encoded by H.
pylori strain 26695. In the current study, we show that this motif is
required for functional activity of the T4SS, and that the C-
terminal motifs of CagI and CagL are required for pilus formation.
Deletion of the C-terminal motif leads to partial mislocalization of
CagH and CagI to a soluble fraction instead of a membrane
fraction (Figure 8E). Based on the observed mislocalization of C-
terminally truncated CagH and CagI proteins, we hypothesize
that this C-terminal motif plays a role in protein sorting or
localization. In several other bacterial species, C-terminal motifs
are required for recognition of proteins by the T4SS machinery.
For example, RalF, an effector molecule of the Legionella Dot/Icm
system, has a C-terminal motif consisting of hydrophobic residues
flanked by lysine/arginine moieties [65]. Mutagenesis studies
indicated that deletion of the distal 3 terminal amino acid residues
of RalF leads to loss of recognition by the T4SS machinery, and
thus loss of translocation [65]. C-terminal translocation signals in
T4SS substrates also have been detected in A. tumefaciens and
Bartonella henselae [66,67]. In a similar manner, we propose that the
conserved C-terminal motifs in CagH, CagI, and CagL target
these proteins to appropriate sites within the H. pylori T4SS.
Interestingly, a mutant strain expressing a C-terminally truncated
form of CagH produced normal-appearing pili, but this strain was
nevertheless defective in both CagA translocation and ability to
stimulate IL-8 induction. This result reveals that contact of these
H. pylori pili with the AGS cell surface is not sufficient to induce IL-
8 production.
T4SSs are a diverse collection of macromolecular machines,
found in a broad phylogenetic range of bacteria. It has been
proposed that all T4SSs employ a common mechanism for
secretion across the cytoplasmic membrane, and that diversity
has arisen primarily as a consequence of variation in the types of
cell envelopes that must be spanned, along with variation in
donor-host cell interactions [29]. Our current understanding of
the architecture of T4SSs is based on elegant work with several
model systems, including the VirB/VirD4 system of A. tumefaciens
and several plasmid conjugation systems. There are limitations,
however, when comparing these model systems with the T4SSs
found in distantly related bacteria. Several components of the H.
pylori cag T4SS are distantly related to components of the VirB/
VirD4 system, and as highlighted in the current study, other key
constituents of the cag T4SS lack homology to components of
T4SSs in other bacterial species. In addition to the three H. pylori
proteins analyzed in the current study, cag T4SS functionality
probably requires at least six other proteins that lack homology to
VirB/VirD4 proteins [21]. In future studies, it will be important
to investigate the functional roles of these proteins in further
detail, and from a broader perspective, it will be important to
investigate the structural correlates of biological diversity among
T4SSs.
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Bacterial Strains and Growth Conditions
H. pylori 26695 and its cag isogenic mutant derivative strains
were grown on trypticase soy agar plates supplemented with 5%
sheep blood or Brucella agar plates supplemented with 5% fetal
bovine serum at 37uC in room air containing 5% CO2. H. pylori
mutant strains were selected based on resistance to chloramphen-
icol (5 mg/ml), kanamycin (10 mg/ml), or metronidazole (7.5 to
15 mg/ml). E. coli strain DH5a, used for plasmid propagation, was
grown on Luria-Bertani agar plates or in Luria-Bertani liquid
medium supplemented with ampicillin (50 mg/ml), chloramphen-
icol (25 mg/ml), or kanamycin (25 mg/ml), as appropriate.
Generation of Rabbit Polyclonal anti-CagL Serum
CagL derived from H. pylori 26695 (and lacking a putative signal
sequence) was expressed as a GST fusion protein from pGEX-6P-
1 vector (GE Healthcare, formerly Amersham). CagL-GST was
purified using gluthathione beads [35]. Rabbits were then
immunized with purified CagL-GST.
Immunoblot Analysis
To detect expression of Cag proteins, individual samples were
separated by SDS-PAGE (4-20% gradient), transferred to a
nitrocellulose membrane, and subsequently immunoblotted using
rabbit polyclonal antiserum raised against recombinant CagL, or
mouse monoclonal antibodies reactive with FLAG or HA epitopes
(Sigma). To confirm similar loading of samples, immunoblotting
using either a monoclonal mouse antibody (Santa Cruz) or a rabbit
polyclonal antiserum to H. pylori HspB, a GroEL homolog, was
utilized [68]. Horseradish peroxidase-conjugated anti-rabbit IgG
or anti-mouse IgG was used as the second antibody. Signals were
generated by enhanced chemiluminescence reaction and detection
by exposure to X-ray film.
Cell Culture Methods
AGS human gastric epithelial cells were grown in the presence
of 5% CO2 in RPMI medium containing 10% FBS, 2 mM L-
glutamine, and 10 mM HEPES buffer.
IL-8 Secretion by Gastric Cells in Contact with H. pylori
H. pylori strains were co-cultured with AGS cells at a multiplicity
of infection of 100:1, and IL-8 secretion was analyzed using an
anti-human IL-8 sandwich ELISA (R&D). Levels of IL-8 secreted
by AGS cells in contact with isogenic cag mutants were compared
to levels secreted by AGS cells in response to infection with WT H.
pylori 26695.
CagA Translocation Assay
Translocation of CagA into AGS cells was analyzed by co-
culturing H. pylori strains with AGS cells and detecting tyrosine
phosphorylation of CagA, as previously described [35,69]. Briefly,
H. pylori and AGS human gastric cells were co-cultured at a MOI
of 100:1 for 24 h at 37uC. Cells were lysed in NP-40 lysis buffer
containing Complete Mini EDTA-free Protease Inhibitor (Roche)
and 2 mM sodium orthovanadate, and CagA translocation was
assessed by separating the soluble fraction using 7.5% SDS-PAGE
and immunoblotting with an anti-phosphotyrosine antibody (a-
PY99, Santa Cruz).
Synthesis of a cat-rdxA Cassette
To facilitate introduction of unmarked mutations into H. pylori
chromosomal genes of interest, a cat-rdxA cassette was synthesized
and cloned into pUC57 vector (Genscript). This cassette confers
resistance to chloramphenicol mediated by the chloramphenicol
acetyl-transferase (cat) gene from Campylobacter coli, and suscepti-
bility to metronidazole is mediated by an intact rdxA gene
(HP0954) from H. pylori 26695. Both genes are in the same
orientation, with cat upstream from rdxA. Expression of cat is driven
by the C. coli cat promoter, and expression of rdxA is driven by the
H. pylori vacA promoter. The two genes are separated by a
presumed C. coli cat terminator, and a FT7 terminator is located at
the 39-distal end of the rdxA gene.
Mutagenesis of H. pylori cag Genes
To construct a DcagL mutant strain, we PCR-amplified cagL
along with approximately 0.5 kb of flanking DNA from H. pylori
26695 genomic DNA using Amplitaq Gold (ABI), and cloned the
PCR product into pGEM-T Easy (Promega). By using this plasmid
as a template for inverse PCR and then ligating the PCR product,
we generated a modified plasmid lacking cagL and containing a
BamHI site at the site of the deletion. A kanamycin resistance
cassette was cloned into the BamHI site to yield pCSLK2-4. H.
pylori 26695 was transformed with pCSLK2-4 (which is unable to
replicate in H. pylori), and single colonies resistant to kanamycin
were selected. PCR and sequencing were used to confirm that the
kanamycin cassette had inserted into the cagL locus in the same
orientation as operon transcription.
To generate unmarked mutant strains, we used a new method
that is a variant of counterselection methods used previously in H.
pylori (Figure 2) [70,71]. As a first step, the rdxA gene, which confers
resistance to metronidazole, as well as approximately 0.5 kb of
flanking DNA on each side, was PCR-amplified from H. pylori
26695 and cloned into pGEM-T Easy to yield pMM670. By using
pMM670 as the template for inverse PCR and then ligating the
PCR product, we generated a modified plasmid (pMM672) in
which the coding region of rdxA was deleted. Transformation of H.
pylori 26695 with pMM672 (which is unable to replicate in H.
pylori) and selection for metronidazole-resistant colonies resulted in
the recovery of a mutant in which the rdxA locus was deleted (H.
pylori DrdxA) (Figure 2A).
For each cag gene of interest, we PCR-amplified the relevant
gene as well as approximately 0.5 kb of flanking DNA on each side
from H. pylori 26695 genomic DNA, and cloned these sequences
into pGEM-T Easy. By using these plasmids as templates for
inverse PCR and then ligating the PCR products, we generated
modified plasmids lacking the cag gene of interest and containing a
BamHI site at the site of the deletion. A cat-rdxA cassette (described
above) was then cloned into the BamHI site. Plasmids containing
the cat-rdxA cassette (which are unable to replicate in H. pylori) were
transformed into H. pylori DrdxA, and single colonies resistant to
chloramphenicol and susceptible to metronidazole were selected
(Figure 2A, B). In each case, PCR analysis confirmed that the cat-
rdxA cassette had inserted into the desired chromosomal site and
that the relevant cag gene was deleted. To generate unmarked
mutants, strains containing the cat-rdxA cassette were transformed
with plasmids harboring the desired mutations, and transformants
resistant to metronidazole were selected (Figure 2A, B). A similar
approach was used to introduce a gene encoding a C-terminally
truncated form of CagL into the endogenous cagL locus.
To complement mutants in cis at a heterologous chromosomal
locus, we used a plasmid derived from pAD1 [72], which allows
genes of interest to be introduced into the H. pylori chromosomal
ureA locus. The modified pAD1 plasmid contains a chloramphen-
icol resistance cassette, restriction sites to allow cloning of a gene of
interest into a site downstream from the ureA promoter and a
ribosomal binding site, and flanking sequences derived from the
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epitope-tagged forms of CagH, CagI, and CagL, and in addition,
plasmids were constructed to allow expression of untagged forms
of CagI and CagL. CagL was expressed as a protein containing a
hemagglutinin (HA) tag introduced at residue 22 immediately
following a putative signal sequence (Figure 1D). CagH was
expressed as a protein containing an N-terminal HA tag, and CagI
was expressed with an internal FLAG epitope introduced at
residue 51 in a region downstream of the predicted signal sequence
(Figure 2C), which is predicted to be surface exposed based on
hydrophilicity plots (ProtScale in Expasy) [73]. H. pylori strains
were transformed with these plasmids, and chloramphenicol-
resistant colonies were selected. Expression of the epitope-tagged
proteins was verified by immunoblotting using monoclonal anti-
HA or anti-FLAG antibodies, respectively.
Immunoaffinity Purification of Cag Proteins
WT or DcagL isogenic mutant bacteria cultured on solid media
were harvested after 48 h of growth, washed once in phosphate-
buffered saline (PBS), and lysed overnight at 4uC in RIPA buffer
(10 mM Tris, 100 mM NaCL, 1% NP-40, 0.25% deoxycholic
acid, Complete Mini EDTA-free Protease Inhibitor (Roche),
pH 7.2). Cellular debris was removed by high speed centrifuga-
tion. CagL was immunoaffinity purified from bacterial lysate using
polyclonal anti-CagL antibodies that had been covalently cross-
linked to a Protein A support (Dynal, Invitrogen). Alternatively,
CagL-HA and CagH-HA were purified from strains expressing
these proteins using monoclonal anti-HA antibodies (Sigma) that
had been either covalently cross-linked or non-covalently bound to
a Protein G support (Dynal, Invitrogen). Immobilized anti-FLAG
M2 antibody (Sigma) was utilized for immunoaffinity purification
of CagI-FLAG. Target proteins were immunoaffinity purified at
room temperature. Immunoaffinity purified proteins were washed
in 100 bed volumes of PBS containing 0.1% Tween-20 (PBST
0.1%) prior to elution by boiling in SDS buffer (0.3 M Tris-HCl,
1% SDS, 10% glycerol, 100 mM DTT, Pierce), or elution by HA
or FLAG peptide competition (1 mg/ml in PBS for HA peptide
[Sigma], 1 mg/ml in TBS for FLAG peptide [Sigma]). In each
case, the presence of the targeted protein in the immunoaffinity
purified sample was verified by immunoblotting.
To purify Cag proteins from bacteria attached to gastric
epithelial cells, the WT strain and a strain expressing CagH-HA
were each co-cultured with AGS cells (80% confluent) at an MOI
of 100 for 5 hours prior to the addition of RIPA buffer and
mechanical disruption of the cell monolayers. Cells were lysed by 3
pulses of sonication (10 s for each pulse), followed by overnight
incubation at 4uC in RIPA buffer. Cleared lysates were incubated
with immobilized anti-HA monoclonal antibody (Sigma) at room
temperature. Immunoaffinity-purified preparations were washed
with 100 bed volumes of PBST 0.1%. Bound proteins were eluted
by HA peptide competition.
Mass Spectrometric Analysis of Samples
To provide a comprehensive analysis of the protein content in
immunoaffinity purified samples, the samples were analyzed by
multidimensional protein identification technology (MudPIT).
Purified proteins were eluted from the beads, run about 2 cm
into a 10% NuPAGE gel, and then subjected to in-gel digestion
with trypsin and peptide extraction. The resulting peptide
mixtures were analyzed via MudPIT essentially as described
[74]. Briefly, peptides were loaded via pressure cell (New
Objective) onto a biphasic pre-column fritted using an Upchurch
M-520 filter union (IDEX). This 100-mm fused silica microcapil-
lary column was packed with 3 cm of 5-mm C18 reverse-phase
resin (Jupiter, Phenomenex) followed by 5 cm of strong cation-
exchange resin (Luna SCX, Phenomenex). Once loaded, it was
then placed in-line with a 100 mm620 cm, C18 packed emitter tip
column (Jupiter C18, 3 mm, 300 A ˚, Phenomonex) coupled to an
LTQ ion trap mass spectrometer equipped with an Eksigent
NanoLC-AS1 Autosampler 2.08, an Eksigent NanoLC-1D plus
HPLC pump, and nanospray source. separations were accom-
plished using 5 ml autosampled pulses of ammonium acetate in
0.1% formic acid (25, 50*, 75, 100, 150*, 200, 250*, 300, 500*,
750*, 1000* mM pulses - * shorter MudPITs containing these salt
pulses were performed on isolated proteins) followed by a 105 min
reversed phase gradient from water 0.1% formic acid to 45%
acetonitrile 0.1% formic acid. Tandem mass spectra were
collected throughout the runs in a data dependent manner using
dynamic exclusion to improve data acquisition of lower intensity
peptides. These spectra were extracted from the instrument files
using ScanSifter and searched using SEQUEST [75] against an H.
pylori strain 26695 database that also contained common
contaminants and reversed versions of the H. pylori proteins.
Identifications were filtered to an estimated desired false discovery
rate (FDR) using reverse database hits and collated to proteins
using IDPicker [76]. All reported proteins were identified with a
minimum of 2 distinct peptides.
Real-time PCR
Total RNA was isolated from H. pylori using Trizol Reagent
(Gibco), according to the manufacturer’s protocol. RNA samples
were refined using the RNeasy Mini Kit (Qiagen), and on-column
RNase-free DNase digestion. cDNA synthesis was performed on
100 ng of purified RNA using the iScript cDNA synthesis kit
(BioRad). As a control, first strand cDNA reactions were carried
out in parallel without reverse transcriptase. Real time PCR was
executed in triplicate on an ABI StepOne Real Time PCR
machine, using TaqMan MGB chemistry. Abundance of cagH,
cagI, and cagL transcripts in cag isogenic mutant strains was
calculated using the DDCT method, with each transcript signal
normalized to the abundance of the recA internal control and
comparison to the normalized transcript levels of WT H. pylori.
Bacterial Subcellular Fractionation
Wild-type H. pylori strain 26695, as well as strains expressing
CagL-HA, CagH-HA or CagI-FLAG, were grown on solid media
for 24 h prior to harvest, washing, and resuspension in sonication
buffer (10 mM Tris-HCL, pH 8.0, Complete Mini EDTA-Free
Protease Inhibitor (Roche)). Bacteria were lysed by 5 pulses of
sonication. Unbroken bacteria and cellular debris were removed
from the lysate by centrifugation at 4500 x g for 10 min. The
supernatant was separated by ultracentrifugation (1 h at 250,000 x
g, 4uC) into a soluble fraction and a total membrane fraction.
Proteins in the soluble fraction were concentrated by methanol-
chloroform precipitation [77] prior to solubilization in reducing
SDS-PAGE buffer (Pierce). The total membrane fraction was
washed three times in sonication buffer, and resuspended in
reducing SDS-PAGE buffer (Pierce). Subcellular fractions were
immunoblotted with anti-CagL, anti-HA and anti-FLAG anti-
bodies, followed by appropriate secondary antibodies, to detect
untagged CagL, CagL-HA, CagH-HA, and CagI-FLAG, respec-
tively.
Cleavage of Surface Proteins by Proteinase K
Susceptibility of surface-exposed H. pylori proteins to digestion
with proteinase K was assessed using a modification of previous
protocols [68]. H. pylori expressing CagH-HA, CagI-FLAG, or
CagL-HA were grown for 24 h on blood agar plates prior to
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RMPI medium, or RPMI medium containing proteinase K (0-
20 mg/ml). Bacteria were incubated for 30 min on ice, and
proteinase K activity then was abrogated by addition of PMSF
(final concentration 2 mM). After washing in RPMI containing
2 mM PMSF, the bacteria were resuspended in SDS sample
buffer and analyzed by SDS-PAGE and immunoblotting. CagH-
HA, CagI-FLAG, and CagL-HA were detected with monoclonal
anti-HA or monoclonal anti-FLAG antibodies. Cleavage of VacA,
which is known to be present on the H. pylori surface [50,51], was
assessed using an anti-VacA antiserum [78]. Cleavage of carbonic
anhydrase was assessed using an antiserum raised against a
periplasmic domain of this protein [52]. Densitometry was
accomplished using Image J software [79]; band densities were
normalized to HspB and compared to control samples that were
not treated with proteinase K.
Flow Cytometry
Bacteria were grown overnight in Brucella broth supplemented
with 5% fetal bovine serum. Bacterial cells were fixed in 4%
paraformaldehyde before staining with primary antibody (mono-
clonal anti-HA [Sigma] or monoclonal anti-FLAG [Sigma]) in
PBS supplemented with 50 mM EDTA and 0.1% BSA, followed
by staining with secondary antibody (goat F(ab’)2 anti-mouse IgG
labeled with Alexa Fluor 488) in PBS supplemented with 0.1%
BSA. Flow cytometry data were collected on a Becton Dickenson
LSR2 instrument using Becton Dickenson FACS Diva 6.1.3
software. 20,000 single cell events were collected for each sample
and analyzed using Tree Star Flow Jo 8.8.2 software.
Immunoelectron Microscopy
H. pylori cells were grown on blood agar plates for 48 h as
described above. Immunogold labeling was performed on whole
bacterial cells as previously described with some modifications
[41]. Briefly, bacterial cells were lifted onto formvar-coated 200
mesh copper TEM grids (Electron Microscopy Sciences). Cells
were washed three times with pre-warmed PBS and incubated in
1% gelatin in PBS for 30 min at 37uC. After blocking, mouse
monoclonal primary antibodies (anti-HA or anti-FLAG) were
applied to the sample grids and incubated for 30 min at 37uC.
Subsequently, grids were washed three times with pre-warmed
PBS and a second blocking step was performed using 1% gelatin in
PBS for 30 min at 37uC. Then goat anti-mouse secondary
antibodies conjugated to 10 nm colloidal gold particles (Ted Pella,
Inc.) were applied and incubated for 30 min at 37uC. Afterward,
grids were washed three times with prewarmed PBS and cells were
negatively stained with 1% ammonium molybdate before being
visualized with a Philips CM-12 transmission electron microscope.
FESEM of H. pylori in Contact with Gastric Epithelial Cells
H. pylori and AGS human gastric cells were co-cultured at a
MOI of 100:1 on tissue culture-treated coverslips (BD Biosciences)
for 4 h at 37uC in the presence of 5% CO2. Cells were fixed with
2.0% paraformaldehyde, 2.5% glutaraldehyde in 0.05 M sodium
cacodylate buffer for 1 h at 37uC. Coverslips were washed with
sodium cacodylate buffer and secondary fixation was performed
with 1% osmium tetroxide at room temperature for 2 h.
Coverslips were washed with sodium cacodylate buffer and
dehydrated with sequential washes of increasing concentrations
of ethanol. Samples were then dried at the critical point, mounted
onto sample stubs, grounded with a thin strip of silver paint at the
sample edge, and sputter-coated with gold before viewing with a
Zeiss Supra 35V FEG scanning electron microscope. Analysis of
pilus dimensions and image analysis was performed using Image J
software [79].
Statistical Analysis
The statistical significance of differences in numbers of spectral
counts of proteins detected in different immunoaffinity purified
preparations was determined by G-test, as previously described
[80]. The statistical significance of differences in IL-8 production
or cag gene expression when comparing WT H. pylori with mutant
strains was determined by one-way ANOVA followed by
Dunnett’s post-hoc test for multiple comparisons against a single
control [81]. Statistical analysis of pilus dimensions was performed
using a two-tailed Student’s T-Test.
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